ANDA Approval Decline Continues, But Why?
Ongoing COVID-19 Disruptions Cited As Possible Cause
US FDA says COVID disruptions may be having an impact; complete response letters have also dropped significantly.
US FDA says COVID disruptions may be having an impact; complete response letters have also dropped significantly.